Assembling intelligence…
CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), PHARMACOVIGILANCE SYSTEM IMPLEMENTATION AND IT LIFECYCLE SUPPORT FOR FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) II PROGRAM
| Company | Orders | Obligated | Latest order end |
|---|---|---|---|
| CHICKASAW STRATEGIC POINTE, LLC | 4 | $24.8M | 2023-06-23 |
| 75F40122F19004 CHICKASAW STRATEGIC POINTE, LLC · Food and Drug Administration | $9.4M | 2023-06-23 |
| 75F40121F19003 CHICKASAW STRATEGIC POINTE, LLC · Food and Drug Administration | $7.1M | 2022-04-11 |
| 75F40120F19001 CHICKASAW STRATEGIC POINTE, LLC · Food and Drug Administration | $5.9M | 2021-04-26 |
| 75F40120F19002 CHICKASAW STRATEGIC POINTE, LLC · Food and Drug Administration | $2.4M | 2021-12-31 |